Length of hospital stay · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Adverse events Assessed by investigators or reported by parents · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Clinical severity score (post‐treatment) at day 1 · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Clinical severity score (post‐treatment) at day 2 · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Clinical severity score (post‐treatment) at day 3 · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Annual hospitalisation rates · infants up to 24 months of age with acute bronchiolitis
Nebulised hypertonic saline may leads to lower rate of hospitalisation compared with nebulised 0.9% saline (low certainty).
1 finding from 1 review
Hospital readmission · infants up to 24 months of age with acute bronchiolitis
Nebulised hypertonic saline showed no clear difference in rate of readmission to hospital compared with nebulised 0.9% saline (low certainty).
1 finding from 1 review
Number of days to resolution of symptoms and signs (wheezing) · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Number of days to resolution of symptoms and signs (cough) · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Number of days to resolution of symptoms and signs(pulmonary moist crackles) · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Improved or corrected strabismusa at 6 or 12 months · adults and children with strabismus
Botulinum toxin may leads to lower improved or corrected strabismusa at 6 or 12 months compared with surgery (low certainty).
1 finding from 1 review
Serious adverse events at 6 or 12 months · adults and children with strabismus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants requiring additional surgery(ies) at 6 or 12 months · adults and children with strabismus
It is very uncertain whether botulinum toxin changes proportion of participants requiring additional surgery(ies) at 6 or… compared with surgery (very low certainty).
1 finding from 1 review
Proportion of participants who achieved binocular single vision at 6 or 12 months · adults and children with strabismus
Botulinum toxin showed no clear difference in proportion of participants who achieved binocular single vision at 6… compared with surgery (low certainty).
1 finding from 1 review
Quality of life (validated questionnaire) · adults and children with strabismus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events at 6 or 12 months · adults and children with strabismus
1 finding from 1 review
Mean daily rating of problem severity (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))
1 finding from 1 review
Mean change in daily rating of functional impairment: reduction of productivity (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))
1 finding from 1 review
Mean change in daily rating of functional impairment: social activities (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))
1 finding from 1 review
Mean change in daily rating of functional impairment: relationship interference (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))
1 finding from 1 review